Thus, the measurement of adiponectin levels in CSF or plasma led to divergent results: reduced levels of adiponectin have been observed in the serum [137] and CSF [138] of AD patients, while in other studies, plasma and CSF adiponectin were significantly higher in MCI and AD compared to controls [139]. The gene discussed is ADIPOQ; the disease is Alzheimer disease.